Hypophagia induced by glucocorticoid deficiency is associated with an increased activation of satiety-related responses.
Glucocorticoids have major effects on food intake, demonstrated by the decrease of food intake following adrenalectomy. Satiety signals are relayed to the nucleus of the solitary tract (NTS), which has reciprocal projections with the arcuate nucleus (ARC) and paraventricular nucleus (PVN) of the hypothalamus. We evaluated the effects of glucocorticoids on the activation of hypothalamic and NTS neurons induced by food intake in rats subjected to adrenalectomy (ADX) or sham surgery 7 days before the experiments. One-half of ADX animals received corticosterone (ADX+B) in the drinking water (B: 25 mg/l). Fos/tyrosine hydroxylase (TH), Fos/corticotrophin-releasing factor (CRF) and Fos immunoreactivity were assessed in the NTS, PVN, and ARC, respectively. Food intake and body weight were reduced in the ADX group compared with sham and ADX+B groups. Fos and Fos/TH in the NTS, Fos, and Fos/CRF immunoreactive neurons in the PVN and Fos in the ARC were increased after refeeding, with higher number in the ADX group, compared with sham and ADX+B groups. CCK administration showed no hypophagic effect on ADX group despite a similar increase of Fos/TH immunoreactive neurons in the NTS compared with sham and ADX+B groups, suggesting that CCK alone cannot further increase the anorexigenic effect induced by glucocorticoid deficiency. The present data indicate that glucocorticoid withdrawal reduced food intake, which was associated with higher activation of ARC, CRF neurons of the PVN, and catecholaminergic neurons of the NTS. In the absence of glucocorticoids, satiety signals elicited during a meal lead to an augmented activation of brain stem and hypothalamic pathways.
Uchoa
Ernane Torres
ET
Avenida Bandeirantes, 3900, 14049-900 Ribeirão Preto, Sao Paulo, Brazil.
Sabino
Henrique Augusto C
HA
Ruginsk
Silvia Graciela
SG
Antunes-Rodrigues
Jose
J
Elias
Lucila Leico K
LL
D000315:Adrenalectomy; D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000378:metabolism / Q000503:physiopathology; D001522:Behavior, Animal; D001835:Body Weight; D002395:Catecholamines / Q000378:metabolism; D002766:Cholecystokinin / Q000008:administration & dosage; D003345:Corticosterone / Q000008:administration & dosage; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D004195:Disease Models, Animal; D004326:Drinking; D004435:Eating; D005215:Fasting; D001068:Feeding and Eating Disorders / Q000378:metabolism / Q000503:physiopathology*; D005938:Glucocorticoids / Q000172:deficiency*; D007031:Hypothalamus / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D009434:Neural Pathways / Q000378:metabolism / Q000503:physiopathology; D009474:Neurons / Q000378:metabolism; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism / Q000503:physiopathology; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012528:Satiety Response; D017552:Solitary Nucleus / Q000378:metabolism / Q000503:physiopathology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D002395:Catecholamines; D005938:Glucocorticoids; D016760:Proto-Oncogene Proteins c-fos; D002766:Cholecystokinin; D003346:Corticotropin-Releasing Hormone; D014446:Tyrosine 3-Monooxygenase; D003345:Corticosterone